June 17, 2009
Clarient's EGFR Mutation Test
Full-text access for premium subscribers only.
Existing premium subscribers
New to GenomeWeb?
Largest Trial of EGFR-Mutated NSCLC Patients Promises New Personalized Treatment Option
June 6, 2012 / Pharmacogenomics Reporter
Clovis, Avila to Co-develop Targeted NSCLC Drug with Companion Test in Deal Worth up to $209M
May 26, 2010 / Pharmacogenomics Reporter
Drugmakers in Third Quarter Focus on Uptake of Newer Personalized Rx to Replace Older Versions
November 6, 2013 / Pharmacogenomics Reporter
Johns Hopkins Team Testing Marker to Predict Resistance to EGFR Inhibitors
September 25, 2013 / Pharmacogenomics Reporter
FDA Okays Boehringer's Gilotrif, Qiagen EGFR Test, Providing New PGx Options for Advanced NSCLC
July 17, 2013 / Pharmacogenomics Reporter